Zhou, Qingmin
Zhao, Xinyuan
Luo, Hangzhou
Funding for this research was provided by:
The value of quantitative blood flow fraction in guiding and evaluating coronary drug-eluting balloon therapy (No. 2021WJCY304)
Article History
Received: 15 September 2025
Accepted: 27 February 2026
First Online: 3 March 2026
Declarations
:
: This study was approved by the Ethics Committee of Hangzhou Second People’s Hospital (Approval No.2022(E2)HS-052). All participants provided written informed consent prior to enrollment.
: Not applicable.
: The authors declare no competing interests.